29 November 2012
Wellcome Collection Conference Centre, 183 Euston Road, London
Each year in the UK at least £1,000,000,000 is wasted through low adherence and misuse of prescribed medicines. Do pharmaceutical physicians/scientists, clinicians and health care professionals condone a high level of waste of medicines? Should we change practice in the development of medicines, prescribing and approval of new therapies that enhance the life of patients?
The Faculty of Pharmaceutical Medicine’s Annual Symposium ‘Life or Livelihood: does adherence to medicine matter?’ brings together leaders in clinical development of medicines and adherence research, regulatory agency leaders, patient advocates, educators and commissioners of NHS services. So, if you are working within the pharmaceutical industry, part of the NHS, wider health sector or have a serious interest in healthcare service delivery and enabling better patient care, then make sure that you don’t miss this essential day.
- Earl Howe Parliamentary Under Secretary of State, Department of Health
- Mark Duman Chair and Director, Patient Information Forum
- Dr Jackie Parkin Medicines Development Leader, GlaxoSmithKline
- Prof Rob Horne Head of Department of Practice & Policy, UCL School of Pharmacy